ArticleInternational journal of biomedical imaging2026
Big Data Analytics Framework for Early Breast Cancer Detection Using Optimized MapReduce and Deep Learning on Large-Scale Mammographic Data.
Article in International journal of biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The paper presents a framework that is aimed at addressing the large-scale data challenge with a particular focus on early prediction of breast cancer based on mammography image data. The abundance of large-scale medical imaging data in healthcare has opened the way to intelligent diagnostic systems through its ability to analyze and process large-scale mammography data. The proposed framework, the metaheuristic optimization based large-scale breast cancer detection (MO-LSBCD) framework provides a complete solution to the extraction of discriminative features that can be used to predict the disease correctly. Early and accurate diagnosis of breast cancer is one of the most critical factors in improving survival rates and reducing treatment costs for patients. The MO-LSBCD framework is divided into three phases: (1) The CBIS-DDSM mammography dataset consists of 10,239 image files with a size of 6 GB, but for classification, the analytical unit is the annotated region of interest (ROI), with 3568 ROI-level abnormality records from 1566 unique patients (normal, malignant, benign, and benign-without-callback); (2) solving the large-scale data problem by implementing an optimized MapReduce model to efficiently distribute and process the large volumes of breast cancer mammography images in parallel; and (3) effective deep learning techniques to classify breast cancer pathology. The experimental findings indicate that the enhanced MapReduce model reduces total processing time and improves F-measure in comparison with the standard MapReduce model. Among different deep learning models tested on the CBIS-DDSM dataset, the classification of EfficientNet-B3 and ResNet-50 was better with an accuracy of 99.64% and 98.91%, respectively, compared with the other models on all evaluation metrics. The results of this paper confirm that MO-LSBCD framework can be used to provide a robust and scalable solution to large-scale breast cancer detection to help clinicians in the early diagnosis of breast cancer and eventually help in the improved patient outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.